Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Donnelly GAE"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD.
Autor: Madaan V; American Psychiatric Association, Washington, DC, USA., Bhaskar S; Imbrium Therapeutics L.P., A Subsidiary of Purdue Pharma L.P., Stamford, CT, USA., Donnelly GAE; Elvium Life Sciences, Toronto, ON, Canada., Cox DJ; University of Virginia Health System, Charlottesville, USA.
Publikováno v: Journal of attention disorders [J Atten Disord] 2024 Apr; Vol. 28 (6), pp. 947-956. Date of Electronic Publication: 2024 Feb 25.
Zobrazit plný text záznamu
3
Akademický článek
Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate.
Autor: van Stralen J; Center for Pediatric Excellence, Ottawa, ON, Canada., Parhar G; Adult ADHD Centre, Burnaby, BC, Canada., Parhar A; Adult ADHD Centre, Burnaby, BC, Canada., Tourjman V; Centre de recherche de l'Institut universitaire en santé mentale de Montréal, Montréal, QC, Canada., Khattak S; Kids Clinic, Ajax, ON, Canada., Ahmed T; Windsor Health Center, Windsor, ON, Canada., Donnelly GAE; Elvium Life Sciences, Toronto, ON, Canada., Ratz J; Elvium Life Sciences, Toronto, ON, Canada.
Publikováno v: Journal of attention disorders [J Atten Disord] 2023 May; Vol. 27 (7), pp. 743-756. Date of Electronic Publication: 2023 May 05.
Zobrazit plný text záznamu
4
Akademický článek
Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension.
Autor: Weiss MD; Child and Adolescent Psychiatry, Cambridge Health Alliance, Cambridge, Massachusetts, USA., Cutler AJ; Department of Psychiatry, Neuroscience Education Institute and SUNY Upstate Medical University, Lakewood Ranch, Florida, USA., Kollins SH; Holmusk, Durham, North Carolina, USA.; Department of Psychiatry & Behavioral Sciences, Duke University, Durham, North Carolina, USA., Donnelly GAE; Purdue Pharma Canada, Pickering, Ontario, Canada.
Publikováno v: Journal of child and adolescent psychopharmacology [J Child Adolesc Psychopharmacol] 2021 Nov; Vol. 31 (9), pp. 610-622. Date of Electronic Publication: 2021 Oct 08.
Zobrazit plný text záznamu
5
Akademický článek
Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension.
Autor: Weiss MD; Cambridge Health Alliance, Cambridge, MA, USA., Childress AC; Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV, USA., Donnelly GAE; Purdue Pharma (Canada), Pickering, ON, Canada.
Publikováno v: Journal of attention disorders [J Atten Disord] 2021 Aug; Vol. 25 (10), pp. 1417-1428. Date of Electronic Publication: 2020 Jan 09.
Zobrazit plný text záznamu
6
Akademický článek
Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study.
Autor: Childress AC; Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, Nevada, USA., Brams MN; Bayou City Research, Ltd., Houston, Texas, USA., Cutler AJ; Neuroscience Education Institute, Lakewood Ranch, Florida, USA.; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York, USA., Donnelly GAE; Purdue Pharma (Canada), Pickering, Canada., Bhaskar S; Imbrium Therapeutics L.P., a subsidiary of Purdue Pharma L.P., Stamford, Connecticut, USA.
Publikováno v: Journal of child and adolescent psychopharmacology [J Child Adolesc Psychopharmacol] 2020 Dec; Vol. 30 (10), pp. 580-589. Date of Electronic Publication: 2020 Oct 22.
Zobrazit plný text záznamu
7
Akademický článek
Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults.
Autor: Katzman MA, Mattingly G, Klassen LJ; Eden Mental Health Centre, Winkler, Manitoba, Canada., Cataldo MJ; Purdue Pharma L.P., Stamford, CT., Donnelly GAE; Purdue Pharma Canada, Pickering, Ontario, Canada.
Publikováno v: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2020 Nov/Dec; Vol. 40 (6), pp. 579-587.
Zobrazit plný text záznamu
8
Akademický článek
The Time Course of Effect of Multilayer-Release Methylphenidate Hydrochloride Capsules: A Randomized, Double-Blind Study of Adults With ADHD in a Simulated Adult Workplace Environment.
Autor: Wigal SB; AVIDA, Newport Beach, CA, USA., Wigal T; AVIDA, Newport Beach, CA, USA., Childress A; Center for Psychiatry and Behavioral Medicine Inc., Las Vegas, NV, USA., Donnelly GAE; Purdue Pharma Canada, Pickering, Ontario, Canada., Reiz JL; Purdue Pharma Canada, Pickering, Ontario, Canada.
Publikováno v: Journal of attention disorders [J Atten Disord] 2020 Feb; Vol. 24 (3), pp. 373-383. Date of Electronic Publication: 2016 Oct 17.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje